Zacks Research Reduces Earnings Estimates for ProAssurance

Key Points

• Zacks Research has reduced its Q2 2025 earnings per share estimate for ProAssurance to $0.19 from $0.20, while the consensus for the current full year is $0.80 EPS.
• ProAssurance's stock has a current consensus rating of "Hold" with a target price of $21.50, as multiple analysts have recently adjusted their ratings.
• The company has reported a decrease in revenue of 4.5% year-over-year, with last quarter's earnings at $0.13 EPS, missing expectations by $0.06.

ProAssurance Corporation (NYSE:PRA - Free Report) - Analysts at Zacks Research dropped their Q2 2025 earnings per share estimates for ProAssurance in a report released on Wednesday, July 23rd. Zacks Research analyst K. Dey now anticipates that the insurance provider will post earnings per share of $0.19 for the quarter, down from their prior estimate of $0.20. The consensus estimate for ProAssurance's current full-year earnings is $0.80 per share. Zacks Research also issued estimates for ProAssurance's FY2025 earnings at $0.87 EPS, Q1 2026 earnings at $0.20 EPS, FY2026 earnings at $1.04 EPS and FY2027 earnings at $1.20 EPS.

Other research analysts also recently issued research reports about the company. Citigroup downgraded ProAssurance to a "market perform" rating in a research note on Thursday, April 3rd. Wall Street Zen started coverage on ProAssurance in a research note on Monday, May 19th. They set a "hold" rating for the company. Piper Sandler boosted their target price on ProAssurance from $18.00 to $25.00 and gave the stock a "neutral" rating in a research note on Thursday, May 8th. Raymond James Financial downgraded ProAssurance from a "market perform" rating to an "underperform" rating in a research note on Thursday, April 10th. Finally, Citizens Jmp downgraded ProAssurance from an "outperform" rating to a "market perform" rating in a research note on Thursday, April 3rd. One research analyst has rated the stock with a sell rating and five have issued a hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $21.50.

ProAssurance Price Performance

PRA stock traded up $0.02 during midday trading on Monday, reaching $23.81. The company had a trading volume of 93,197 shares, compared to its average volume of 660,866. The company has a market capitalization of $1.22 billion, a price-to-earnings ratio of 29.03 and a beta of 0.12. The stock has a 50 day moving average price of $23.32 and a 200-day moving average price of $20.54. ProAssurance has a 1-year low of $11.27 and a 1-year high of $23.95. The company has a debt-to-equity ratio of 0.34, a current ratio of 0.26 and a quick ratio of 0.26.

ProAssurance (NYSE:PRA - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The insurance provider reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.19 by ($0.06). The company had revenue of $236.28 million during the quarter, compared to analyst estimates of $272.85 million. ProAssurance had a net margin of 3.72% and a return on equity of 4.51%. The firm's revenue for the quarter was down 4.5% compared to the same quarter last year. During the same period last year, the firm earned $0.08 EPS.

Institutional Trading of ProAssurance

Hedge funds and other institutional investors have recently made changes to their positions in the company. Sterling Capital Management LLC boosted its holdings in ProAssurance by 859.4% in the fourth quarter. Sterling Capital Management LLC now owns 1,631 shares of the insurance provider's stock valued at $26,000 after acquiring an additional 1,461 shares during the last quarter. Quantbot Technologies LP acquired a new position in ProAssurance in the first quarter valued at approximately $47,000. GAMMA Investing LLC lifted its stake in ProAssurance by 307.3% in the first quarter. GAMMA Investing LLC now owns 2,073 shares of the insurance provider's stock valued at $48,000 after buying an additional 1,564 shares during the period. CWM LLC lifted its stake in ProAssurance by 95.9% in the first quarter. CWM LLC now owns 2,204 shares of the insurance provider's stock valued at $51,000 after buying an additional 1,079 shares during the period. Finally, Longfellow Investment Management Co. LLC acquired a new position in ProAssurance in the first quarter valued at approximately $75,000. 85.58% of the stock is currently owned by institutional investors.

About ProAssurance

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.